Cargando…
Characterizing patient compliance over six months in remote digital trials of Parkinson’s and Huntington disease
BACKGROUND: A growing number of clinical trials use various sensors and smartphone applications to collect data outside of the clinic or hospital, raising the question to what extent patients comply with the unique requirements of remote study protocols. Compliance is particularly important in condi...
Autores principales: | Cohen, Shani, Waks, Zeev, Elm, Jordan J., Gordon, Mark Forrest, Grachev, Igor D., Navon-Perry, Leehee, Fine, Shai, Grossman, Iris, Papapetropoulos, Spyros, Savola, Juha-Matti |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6302308/ https://www.ncbi.nlm.nih.gov/pubmed/30572891 http://dx.doi.org/10.1186/s12911-018-0714-7 |
Ejemplares similares
-
The Safety of Deutetrabenazine for Chorea in Huntington Disease: An Open-Label Extension Study
por: Frank, Samuel, et al.
Publicado: (2022) -
Pharmacokinetics, metabolism and safety of deuterated L‐DOPA (SD‐1077)/carbidopa compared to L‐DOPA/carbidopa following single oral dose administration in healthy subjects
por: Schneider, Frank, et al.
Publicado: (2018) -
A PET-CT study on neuroinflammation in Huntington’s disease patients participating in a randomized trial with laquinimod
por: Roussakis, Andreas-Antonios, et al.
Publicado: (2023) -
Digital Health Revolution: Is it Time for Affordable Remote Monitoring for Parkinson’s Disease?
por: Papapetropoulos, Spyros, et al.
Publicado: (2015) -
Pridopidine activates neuroprotective pathways impaired in Huntington Disease
por: Geva, Michal, et al.
Publicado: (2016)